---
title: "GPBAR1"
date: 2023-05-13 00:00:00
layout: post
categories: Gene
summary: "# Information about Gene GPBAR1"
tags: ['GeneGPBAR1', 'BileAcidRegulation', 'MetabolicDisorders', 'Cancer', 'GPBAR1Agonists', 'DrugResponse', 'TGR5', 'InflammatoryProcesses']
---

# Information about Gene GPBAR1

## Genetic Position, Pathology, and Function
Gene GPBAR1 is located on the human chromosome 2q24.2 and encodes for the G protein-coupled receptor GPBAR1 also known as TGR5. GPBAR1 plays a role in the regulation of bile acid homeostasis and energy metabolism. Recent studies have also shown its involvement in glucose homeostasis, inflammatory processes, and tumorigenesis. Aberrations in GPBAR1 expression or function have been associated with various diseases including metabolic disorders and cancer.

## Function of Gene 
GPBAR1 is involved in the regulation of bile acid synthesis, transport, and secretion. It is also involved in energy metabolism by regulating glucose and lipid metabolism in various tissues. Furthermore, GPBAR1 activation has been implicated in regulating inflammatory processes and tumorigenesis.

## External IDs and Genomic Location/Aliases
- HGNC ID: 29252
- NCBI Entrez Gene ID: 151306
- Ensembl ID: ENSG00000213581
- OMIM ID: 611015
- UniProtKB/Swiss-Prot ID: Q8TDU6
- Genomic Location: Chromosome 2q24.2
- Aliases: TGR5, M-BAR, BG37, GPBAR

## AA Mutation List and Mutation Type with dbSNP ID
None reported.

## Somatic SNVs/InDels with dbSNP ID
None reported.

## Related Disease
Disorders associated with GPBAR1 abnormalities include metabolic disorders such as obesity, type 2 diabetes, and dyslipidemia. Additionally, GPBAR1 has been implicated in the development and progression of certain cancers.

## Treatment and Prognosis
Studies are ongoing to evaluate GPBAR1 agonists and antagonists as potential therapeutic agents for metabolic disorders and cancer. The prognosis for disorders related to GPBAR1 abnormalities will depend on the specific disease and its severity.

## Drug Response
GPBAR1 agonists may improve insulin resistance, glucose tolerance, and lipid metabolism in patients with metabolic disorders. However, further research is needed to determine the efficacy and safety of these drugs.

## Related Papers
- Subject: The TGR5 receptor mediates bile acid-induced itch and analgesia
  - Author: Steinhoff MS, von Mentzer B, Geppetti P, Pothoulakis C, Bunnett NW
  - DOI: 10.1016/j.jaci.2015.08.014
  
- Subject: GPBAR1/TGR5 mediates bile acid-induced cytokine expression in murine Kupffer cells
  - Author: Liao L, Schneider KM, Galvez EJ, Frissen M, Marschall HU, Su H, Hatting M, Wahlström A, Haybaeck J, Puchner MJ, Longerich T, Strowig T, Hasler F, de Vos WM, Miele L, Beuers U, Manns MP, Heinrichs D, Akira S, Müller M, Li F, Schwabe RF
  - DOI: 10.1172/JCI73888

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**